Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shi-cha capsule
- Development stage
- Phase 2
- Lead developer
- West China Hospital of Sichuan University
- Administration
- Oral
01
Overview
Shi-cha capsule is a Traditional Chinese Medicine (TCM) herbal formula developed by the Department of Integrated Traditional Chinese and Western Medicine at West China Hospital, Sichuan University. It is specifically formulated for the treatment of the "wind-cold" type of the common cold. The formula is designed to alleviate symptoms such as fever, chills, headache, and nasal congestion associated with viral upper respiratory tract infections. As a botanical product, its mechanism likely involves a multi-target approach including anti-inflammatory, antiviral, and antipyretic activities derived from its constituent herbs. It has been evaluated in clinical trials to determine its therapeutic efficacy, safety, and optimal dosage.
- Brand names
- Shi-cha capsule
- Other names
- Shicha capsule
Beyond the preview
Go deeper on Shi-cha capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shi-cha capsule.